18 research outputs found
WS12.1 Evidence of diminished FEV1 in CF 6-year-olds followed in the European CF registry, 2007–2009
Get PDFWS3.1 The effect of ivacaftor on the rate of lung function decline in CF patients with a G551D-CFTR mutation
Get PDF180 Choice of IV vs. non-IV antibiotics for treating pulmonary exacerbations in patients with cystic fibrosis
Get PDFWS12.1 Evidence of diminished FEV1 in CF 6-year-olds followed in the European CF registry, 2007–2009
No full textPRM139 Including Patients in Multiple Groups and Multiple Times in the Same Group in Longitudinal Observational Research: A Cystic Fibrosis Example
No full textPRM4 A MIXED-Effects Piecewise Linear Model Of The Rate Of Lung Function Decline Before And After Inhaled Corticosteroids In An Observational Study Of Children With Cystic FIBROSIS
No full textPND67 A Mixed-Effects Piecewise Linear Model of the Rate of Lung Function Decline Before and After the Clinical Use of Dornase Alfa in an Observational Study of Cystic Fibrosis
No full text337 Changing incidence and thresholds for pulmonary exacerbation treatment, North America 1995-2005
No full textDEMOGRAPHIC AND CLINICAL PARAMETERS ASSOCIATED WITH USE OF MEDICAL THERAPY AT ENROLMENT IN THE BPH REGISTRY AND PATIENT SURVEY
No full textWS3.1 The effect of ivacaftor on the rate of lung function decline in CF patients with a G551D-CFTR mutation
No full text
